← brief for 2026-09-19 · Slowing decline

What is the efficacy of SGLT2 inhibitors in slowing the progression of chronic kidney disease (CKD)?

Article No results yet Not peer reviewed

Key takeaways

This item is a preprint, not a fully reviewed journal article. It states that SGLT2 drugs help slow kidney decline. It says these drugs lower the risk of kidney failure. However, it does not provide specific data or trial results in this text.

Who did this work

Tripdatabase (Triphase (Belgium))

Source

Article · OpenAlex, CKD works · 2026-09-18
https://doi.org/10.5281/zenodo.22834715